Revenue | ₹1,918.48Cr |
Net Profits | ₹184.71Cr |
Net Profit Margins | 9.63% |
Alembic Pharmaceuticals Ltd’s revenue jumped 14.3% since last year same period to ₹1,918.48Cr in the Q2 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 11.72% jump in its revenue since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit jumped 20.4% since last year same period to ₹184.71Cr in the Q2 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 19.65% jump in its net profits since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit margin jumped 5.34% since last year same period to 9.63% in the Q2 2025-2026. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 7.09% jumped in its net profit margins since last 3-months.
The revenue for Alembic Pharmaceuticals Ltd in the Q2 results 2025 was ₹1,918.48Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q2 results 2025 was ₹184.71Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q2 results 2025 was 9.63%.
The revenue for Alembic Pharmaceuticals Ltd in the Q2 results 2024 was ₹1,678.45Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q2 results 2024 was ₹153.41Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q2 results 2024 was 9.14%.